NasdaqCM - Delayed Quote USD
Elicio Therapeutics, Inc. (ELTX)
5.49
-0.08
(-1.44%)
At close: May 9 at 4:00:00 PM EDT
5.22
-0.27
(-4.92%)
After hours: May 9 at 5:29:05 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-37,068
-37,068
-32,694
-22,179
-23,939.05
Investing Cash Flow
-84
-84
-32
-654
-525.36
Financing Cash Flow
42,321
42,321
38,613
21,202
19,393.57
End Cash Position
19,492
19,492
14,301
8,414
10,044.51
Capital Expenditure
-87
-87
-66
-654
-525.36
Issuance of Capital Stock
5,635
5,635
6,999
21,120
5,046.68
Issuance of Debt
19,727
19,727
10,000
0
14,470
Repayment of Debt
--
--
--
0
-437.99
Repurchase of Capital Stock
--
--
-150
0
--
Free Cash Flow
-37,155
-37,155
-32,760
-22,833
-24,464.40
12/31/2021 - 2/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IVA Inventiva S.A.
3.6200
+4.02%
ENTX Entera Bio Ltd.
2.1500
-3.15%
ACTU Actuate Therapeutics, Inc. Common stock
10.35
+4.55%
AARD Aardvark Therapeutics, Inc.
10.42
-2.89%
ERAS Erasca, Inc.
1.3900
0.00%
RLYB Rallybio Corporation
0.2930
0.00%
ENTO Entero Therapeutics, Inc.
0.4190
+5.09%
ELVAF Evolva Holding SA
0.9000
0.00%
EMBT Ember Therapeutics, Inc.
0.0001
0.00%
BETRF BetterLife Pharma Inc.
0.0660
0.00%